No profile data available.
Mind Medicine (MindMed) Inc. (MNMD) is a healthcare company in the brain and nerve treatment drugs industry, based in New York, United States, with about 74 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$108.68 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $1.46 billion as of January 14, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of January 14, 2026.
, a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.
Mind Medicine (MindMed) reported $0 in revenue for fiscal year 2024. In Q2 2026 revenue was $0.
$1.46 billion as of January 14, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Stoke Therapeutics, Inc. (STOK), Rapport Therapeutics, Inc. (RAPP), Taysha Gene Therapies, Inc. (TSHA), GH Research PLC (GHRS).